Shorts
0:36
Continuous vs Time-Limited: Navigating the Major Shift in CLL Care
5 months ago
by
Marc S. Hoffmann, MD
0:48
Beyond Standard Care: Navigating p53 Aberrant and 17p Deleted CLL
5 months ago
by
Marc S. Hoffmann, MD
0:33
How to Potentially Prevent 44% of Cancer Cases
5 months ago
by
Rebecca Siegel, MPH
0:52
Is Stage IV Lung Cancer Incurable? A New Breakthrough Says Otherwise
5 months ago
by
Saiesh Reddy Voppuru, MD
0:45
Why Healthcare Must Embrace AI or Face Collapse
5 months ago
by
Debra Patt, MD, PhD, MBA
1:06
Why 2026 is a Call to Action for Oncology Innovation
5 months ago
by
Debra Patt, MD, PhD, MBA
1:00
Why Drug Prices Are Actually Rising: The 340B Effect
5 months ago
by
Debra Patt, MD, PhD, MBA
0:41
The Challenges of Treating Systemic Brain Metastases
5 months ago
by
Manmeet Ahluwalia, MD
0:59
From 6 Months to 5 Years: The New Era of Brain Metastasis Survival
5 months ago
by
Manmeet Ahluwalia, MD
0:34
A Safe Hair Loss Solution During Cancer Treatment
5 months ago
by
Brittany Dulmage, MD
0:35
The CAR T Gap: Why Effectiveness Isn't the Problem
5 months ago
by
Marc S. Hoffmann, MD
0:34
The Truth About Vitamins for Cancer-Related Hair Loss
5 months ago
by
Brittany Dulmage, MD
1:14
The Hidden Danger of Biotin During Cancer Treatment
5 months ago
by
Brittany Dulmage, MD
0:38
"If You Have Lungs, You Can Have Lung Cancer"
5 months ago
by
Bruna Pellini, MD
0:33
What Patients Are Really Doing for Hair Loss
5 months ago
by
Brittany Dulmage, MD
1:02
Is Liquid Biopsy the Future of Cancer Detection?
5 months ago
by
Bruna Pellini, MD
0:40
Why We Use Supportive Care: Making Patients Feel Better
5 months ago
by
Martin Dietrich, MD, PhD
0:39
The Missing Link in Patient Care: Improving Survival and Quality
5 months ago
by
Uma Borate, MBBS
0:35
Blood Cancer Trials Aren’t Reaching Most Older Patients
5 months ago
by
Inna Gong, MD, PhD
0:50
Beyond Chemo: New Hope for Ovarian Cancer
5 months ago
by
Brian Slomovitz, MD, MS, FACOG
0:39
Unlocking New Therapeutic Opportunities in Pancreatic Cancer With NGS
5 months ago
by
Shubham Pant, MD
0:20
Pan-RAS Inhibitors: Penetrating Pancreatic Cancer’s Defenses
5 months ago
by
Shubham Pant, MD
0:39
Efficacy Results: Can Patients with TP53 Mutations Reach Remission?
5 months ago
by
Uma Borate, MBBS
0:37
The Decade-Long Struggle in MDS Treatment
5 months ago
by
Uma Borate, MBBS
0:39
Why Some Cancer Patients Are Being Left Behind In Clinical Trials
5 months ago
by
Uma Borate, MBBS
0:31
Continuous vs Fixed: Which Offers the Longest Survival in CLL?
5 months ago
by
Marc J. Braunstein, MD, PhD(+1 more)
0:37
Who Decides on Cancer Care?
5 months ago
by
John M. Burke, MD(+1 more)
0:31
Improving Quality of Life During Cancer Treatment
5 months ago
by
Martin Dietrich, MD, PhD
1:04
The Real Goal of Health Care: Treating the Person, Not the Trial
5 months ago
by
Chandler H. Park, MD(+2 more)
0:33
How to Build a Successful Community Oncology Practice
5 months ago
by
Benjamin Garmezy, MD(+2 more)
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Divarasib Improves Survival Vs Approved KRAS G12C Inhibitors in NSCLC
2
Zoldonrasib Combos, Including With Daraxonrasib, Yield High Response Rates in PDAC
3
How a Virtual Behavioral Health Program Is Reaching Patients With Cancer Who Need It Most
4
Examining the Strongest Options for Heavily Pretreated Myeloma After Bispecific Therapy
5